Empagliflozin Prescribing at REGENT SQUARE GROUP PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
1,665
Total Quantity
44.8K
NHS Cost
£55.7K
vs National Avg
+166.1%
REGENT SQUARE GROUP PRACTICE prescribed 1,665 items of Empagliflozin over the last 12 months at a cost of £55,663 to the NHS. This is 166.1% above the national average prescribing rate. Empagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
129
Jun 2026
120
Jun 2026
148
Jun 2026
154
Jun 2026
128
Jun 2026
149
Jun 2026
143
Jun 2026
144
Jun 2026
151
Jun 2026
130
Jun 2026
134
Jun 2026
135
Prescribing Details
| Total Items | 1,665 |
|---|---|
| Total Quantity | 44,809 |
| Total NHS Cost | £55,663 |
| Presentations | 2 different forms |
| vs National Average | +166.1% |
Empagliflozin Prescribing Comparison
| This practice | 1,665 items |
|---|---|
| National average per practice | 626 items |
| Difference | +166.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.